Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657772 · ClinicalTrials.gov registry record
Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 100
- Enrollment target
NCT02657772: Completed study, sponsored by University of Maryland, Baltimore.
NCT02657772 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657772 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy rates of the treatment of small intracranial aneurysms with Stryker Neurovascular's Target® 360 Ultra coils which are a type of platinum coils used to occlude aneurysms.
Primary Outcome
Target Aneurysm Recurrence (TAR) - defined as clinically relevant recurrence resulting in: target aneurysm re-intervention, rupture/re-rupture, and/or death from unknown cause as assessed at 9-18 months post procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-11 |
| Est. Completion | 2021-03 |
What the finished NCT02657772 record still lists
NCT02657772 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02657772 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02657772 about?
NCT02657772 is a clinical study titled "Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms". The purpose of this study is to assess the safety and efficacy rates of the treatment of small intracranial aneurysms with Stryker Neurovascular's Target® 360 Ultra coils which are a type of platinum coils used to occlude aneurysms.
What is the current status of trial NCT02657772?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-11. Estimated completion is 2021-03.
Who is sponsoring clinical trial NCT02657772?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia